Skip to main content
OpenTrials
Completed

NCT Number: NCT02419599

High vs Standard Energy Children's Drink Study

This study is a pilot trial investigating the effects of a high energy drink for children, in comparison to standard energy drink for children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

A four week, multi-centre, randomised controlled trial investigating the effects of a high energy density, low volume oral nutritional supplement versus standard energy density oral nutritional supplements in children aged 1-12yrs old requiring nutritional support. Fifty eligible children will be recruited and randomised to receive either the high energy density oral nutritional supplement or the standard energy density oral nutritional supplement for four weeks. The primary outcome is nutrient intake, with secondary outcomes of compliance, tolerance, acceptability, anthropometry and safety.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female
  • Aged 1-12yrs
  • Faltering growth and/or requiring oral nutritional supplements to meet nutritional requirements
  • Expected to receive at least one bottle of the study product per day
  • Able to take study products orally during the study period
  • Written informed consent from parent/carer

Exclusion criteria

  • Requirement for 100% of their nutrition via enteral tube and/or parenteral feeding.
  • Children with major hepatic or renal dysfunction
  • Children with galactosaemia or severe lactose intolerance
  • Requirement for elemental or semi-elemental feeds
  • Investigator concern around willingness/ability of child/parent/carer to comply with protocol requirements
  • Participation in other studies within 2 weeks of study

Treatment and study plan

HE ONS

Other

High energy density, low volume oral nutritional supplement (HE ONS) in addition to appropriate nutritional management

SE ONS

Other

Standard energy density oral nutritional supplement (SE ONS) in addition to appropriate nutritional management

Primary outcomes

  1. Nutrient intake

    Time frame: 4 weeks (28 days)

    Dietary intake, including the intake of all foods and fluids, will be recorded and analysed throughout the study.

Secondary outcomes

  1. Compliance: Compliance with oral nutritional supplements in Group A and Group B; how much of the oral nutritional supplement is taken in comparison to the amount advised by the Dietitian.

    Time frame: 4 weeks (28 days)

  2. Tolerance: How well the child tolerates the oral nutritional supplements (including changes to gastrointestinal symptoms)

    Time frame: 4 weeks (28 days)

  3. Acceptability: How acceptable the oral nutritional supplement is to the child and their parent/carer, including taste, texture, ease of use, etc.

    Time frame: 4 weeks (28 days)

  4. Anthropometry

    Time frame: 4 weeks (28 days)

    Changes to weight, height and head circumference in children less than 2yrs of age.

  5. Safety assessed by adverse events, to be recorded throughout study.

    Time frame: 4 weeks (28 days)

Sponsors and collaborators

Lead sponsor

Nutricia UK Ltd

Industry

Registry information

Official study title

The Effect of Standard Versus High Energy Density, Low Volume Oral Nutritional Supplements in Children Requiring Nutritional Support - a Pilot Trial

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 17, 2015
Registry last updated
Nov 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.